Search Within

NEUROBLASTOMA

Cilostazol: Therapeutic Potential Against Focal Cerebral Ischemic Damage

Journal: Current Pharmaceutical Design
Volume: 12,Issue: 5
Page: 565-573
Authors: Ki W. Hong, Jeong H. Lee, Ki Y. Kim, So Y. Park and Won S. Lee

Choline Kinase: An Important Target for Cancer

Journal: Current Medicinal Chemistry
Volume: 13,Issue: 10
Page: 1169-1186
Authors: S. Janardhan, P. Srivani and G. N. Sastry

Molecularly Guided Therapy of Neuroblastoma: A Review of Different Approaches

Journal: Current Pharmaceutical Design
Volume: 12,Issue: 18
Page: 2303-2317
Authors: Gian P. Tonini and Vito Pistoia

Tachykinins and their Receptors in Human Malignancies

Journal: Current Drug Targets
Volume: 7,Issue: 8
Page: 1043-1052
Authors: Carla Palma

Estrogens and Thyroid Hormones: Non-Genomic Effects are Coupled to Transcription

Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Volume: 6,Issue: 3
Page: 267-280
Authors: X. Zhao, D W. Pfaff and N. Vasudevan

Targeting Focal Adhesion Kinase in Neuroblastoma

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10,Issue: 10
Page: 714-721
Authors: Lauren Gillory and Elizabeth A. Beierle

Experimental Models of Discovery: Prediction and Protection must Proceed “Hand-in-Hand”

Journal: Current Neurovascular Research
Volume: 4,Issue: 2
Page: 73-73
Authors: Kenneth Maiese

Establishment of Cholinergic Neuron-like Cell Lines with Differential Vulnerability to Nitrosative Stress

Journal: Current Neurovascular Research
Volume: 4,Issue: 2
Page: 75-88
Authors: David A. Personett, Katrina Williams, Karen A. Baskerville and Michael McKinney


Cyclopentenyl Cytosine (CPEC): An Overview of its in vitro and in vivo Activity

Journal: Current Cancer Drug Targets
Volume: 7,Issue: 5
Page: 504-509
Authors: K.J.M. Schimmel, H. Gelderblom and H.J. Guchelaar

Molecular and Biological Heterogeneity in Neuroblastoma

Journal: Current Genomics
Volume: 6,Issue: 5
Page: 319-332
Authors: E. Hiyama and K. Hiyama

The MYCN Oncogene as a Specific and Selective Drug Target for Peripheral and Central Nervous System Tumors

Journal: Current Cancer Drug Targets
Volume: 5,Issue: 4
Page: 273-283
Authors: Andrea Pession and Roberto Tonelli

Role of Genomics-Based Strategies in Overcoming Chemotherapeutic Resistance

Journal: Current Pharmaceutical Biotechnology
Volume: 5,Issue: 5
Page: 471-480
Authors: M. Vijay Kumar, Robert Shirley, Yulin Ma and Ronald W. Lewis

Heparin Affin Regulatory Peptide: A New Target for Tumour Therapy?

Journal: Current Cancer Drug Targets
Volume: 4,Issue: 6
Page: 471-482
Authors: E. Papadimitriou, A. Polykratis, M. Hatziapostolou, A. Parthymou, C. Polytarchou and C. Mikelis

Eph Receptor Tyrosine Kinases in Tumor and Tumor Microenvironment

Journal: Current Pharmaceutical Design
Volume: 10,Issue: 27
Page: 3431-3442
Authors: Dana Brantley-Sieders, Sonja Schmidt, Monica Parker and Jin Chen

Bombesin-like Peptides: Candidates as Diagnostic and Therapeutic Tools

Journal: Current Pharmaceutical Design
Volume: 9,Issue: 12
Page: 1013-1022
Authors: B. C. Yegen

Iron Chelators as Anti-Neoplastic Agents: Current Developments and Promise of the PIH Class of Chelators

Journal: Current Medicinal Chemistry
Volume: 10,Issue: 12
Page: 1035-1049
Authors: D. B. Lovejoy and D. R. Richardson

The MYC Oncogene as a Cancer Drug Target

Journal: Current Cancer Drug Targets
Volume: 3,Issue: 3
Page: 163-175
Authors: Heiko Hermeking

Cytostatic Properties of Some Angiotensin I Converting Enzyme Inhibitors and of Angiotensin II Type I Receptor Antagonists

Journal: Current Pharmaceutical Design
Volume: 9,Issue: 9
Page: 751-761
Authors: Agostino Molteni, William F. Ward, Chung H. Ts'ao, JoAnn Taylor, William Small Jr., Loredana Brizio-Molteni and Patricia A. Veno

Applications of Gene Transfer to Targeted Radiotherapy

Journal: Current Pharmaceutical Design
Volume: 6,Issue: 14
Page: 1419-1432
Authors: R. J. Mairs, S. H. Cunningham, M. Boyd and S. Carlin

Ligand-Targeted Liposomal Therapies of Neuroblastoma

Journal: Current Medicinal Chemistry
Volume: 14,Issue: 29
Page: 3070-3078
Authors: Fabio Pastorino, Danilo Marimpietri, Chiara Brignole, Daniela Di Paolo, Gabriella Pagnan, Antonio Daga, Federica Piccardi, Michele Cilli, Theresa M. Allen and Mirco Ponzoni

Editorial [Hot Topic:Treatment of Neuroblastoma: From Cellular to Molecular Therapy (Executive Editor: Gian Paolo Tonini)]

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 4
Page: 422-423
Authors: Gian Paolo Tonini

Cellular Immunotherapy for Neuroblastoma: A Review of Current Vaccine and Adoptive T Cell Therapeutics

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 4
Page: 424-429
Authors: C. U. Louis and M. K. Brenner

Apoptosis Pathways and Neuroblastoma Therapy

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 4
Page: 430-435
Authors: S. Fulda

Targeting Histone Deacetylases in Neuroblastoma

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 4
Page: 436-447
Authors: O. Witt, H. E. Deubzer, M. Lodrini, T. Milde and I. Oehme

Genome and Transcriptome Analysis of Neuroblastoma Advanced Diagnosis from Innovative Therapies

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 4
Page: 448-455
Authors: S. Coco, G. P. Tonini, S. Stigliani and P. Scaruffi

MicroRNA Involvement in the Pathogenesis of Neuroblastoma: Potential for MicroRNA Mediated Therapeutics

Journal: Current Pharmaceutical Design
Volume: 15,Issue: 4
Page: 456-462
Authors: R. L. Stallings

Ferulic Acid-Loaded Lipid Nanostructures as Drug Delivery Systems for Alzheimers Disease: Preparation, Characterization and Cytotoxicity Studies

Journal: Current Nanoscience
Volume: 5,Issue: 1
Page: 26-32
Authors: M. L. Bondi, G. Montana, E. F. Craparo, P. Picone, G. Capuano, M. Di Carlo and G. Giammona

Targeting Myc in Pediatric Malignancies of the Central and Peripheral Nervous System

Journal: Current Cancer Drug Targets
Volume: 9,Issue: 2
Page: 176-188
Authors: Michael A. Grotzer, Deborah Castelletti, Giulio Fiaschetti, Tarek Shalaby and Alexandre Arcaro

The PI3K/Akt/mTOR Pathway as Therapeutic Target in Neuroblastoma

Journal: Current Cancer Drug Targets
Volume: 9,Issue: 6
Page: 729-737
Authors: S. Fulda

Recent Advances in Targeted Anti-Vasculature Therapy: The Neuroblastoma Model

Journal: Current Drug Targets
Volume: 10,Issue: 10
Page: 1021-1027
Authors: F. Pastorino, D. Di Paolo, M. Loi, P. Becherini, I. Caffa, A. Zorzoli, D. Marimpietri, R. Carosio, P. Perri, P. G. Montaldo, C. Brignole, G. Pagnan, D. Ribatti, T. M. Allen and M. Ponzoni

Oxidative Stress-Induced Necrotic Cell Death via Mitochondira-Dependent Burst of Reactive Oxygen Species

Journal: Current Neurovascular Research
Volume: 6,Issue: 4
Page: 213-222
Authors: Kyungsun Choi, Jinho Kim, Gyung W. Kim and Chulhee Choi

Cancer Vaccines: Emphasis on Pediatric Cancers

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 3
Page: 292-299
Authors: Terri Guinipero and Olivera J. Finn

Nitric Oxide Control of MYCN Expression and Multi Drug Resistance Genes in Tumours of Neural Origin

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 4
Page: 431-439
Authors: Antonio Porro, Christophe Chrochemore, Francesco Cambuli, Nunzio Iraci, Antonio Contestabile and Giovanni Perini

Nitric Oxide Control of Proliferation in Nerve Cells and in Tumor Cells of Nervous Origin

Journal: Current Pharmaceutical Design
Volume: 16,Issue: 4
Page: 440-450
Authors: Emiliano Pena-Altamira, Paolo Petazzi and Antonio Contestabile

Valproic Acid in the Complex Therapy of Malignant Tumors

Journal: Current Drug Targets
Volume: 11,Issue: 3
Page: 361-379
Authors: J. Hrebackova, J. Hrabeta and T. Eckschlager

Anaplastic Lymphoma Kinase as a Therapeutic Target in Anaplastic Large Cell Lymphoma, Non-Small Cell Lung Cancer and Neuroblastoma

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10,Issue: 3
Page: 236-249
Authors: Mangeng Cheng and Gregory R. Ott

Anti-GD2 Antibody Therapy for GD2-Expressing Tumors

Journal: Current Cancer Drug Targets
Volume: 10,Issue: 2
Page: 200-209
Authors: F. Navid, V. M. Santana and R. C. Barfield

Curcumin Entrapped Into Lipid Nanosystems Inhibits Neuroblastoma Cancer Cell Growth and Activates Hsp70 Protein

Journal: Current Nanoscience
Volume: 6,Issue: 5
Page: 439-445
Authors: M. L. Bondì, E. F. Craparo, P. Picone, M. Di Carlo, R. Di Gesu, G. Capuano and G. Giammona

Hsp20 Protects Neuroblastoma Cells from Ischemia/Reperfusion Injury by Inhibition of Apoptosis via a Mechanism that Involves the Mitochondrial Pathways

Journal: Current Neurovascular Research
Volume: 7,Issue: 4
Page: 281-287
Authors: Liuwang Zeng, Jieqiong Tan, Zhiping Hu, Wei Lu and Binbin Yang

Molecular Mechanisms of Anti-cancer Action of Garlic Compounds in Neuroblastoma

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 11,Issue: 4
Page: 398-407
Authors: Surajit Karmakar, Subhasree Roy Choudhury, Naren L. Banik and Swapan K. Ray

Polyisoprenylation Potentiates the Inhibition of Polyisoprenylated Methylated Protein Methyl Esterase and the Cell Degenerative Effects of Sulfonyl Fluorides

Journal: Current Cancer Drug Targets
Volume: 11,Issue: 6
Page: 752-762
Authors: B. Aguilar, F. Amissah, R. Duverna and N. S. Lamango

Targeting ATP7A to Increase the Sensitivity of Neuroblastoma Cells to Retinoid Therapy

Journal: Current Cancer Drug Targets
Volume: 11,Issue: 7
Page: 826-836
Authors: B. B. Cheung and G. M. Marshall

Implication of Possible Therapies Targeted for the Tachykinergic System with the Biology of Neurokinin Receptors and Emerging Related Proteins

Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 2,Issue: 1
Page: 79-84
Authors: Pranela Rameshwar

C-peptide and Neuropathy in Type 1 Diabetes

Journal: Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Volume: 7,Issue: 1
Page: 69-77
Authors: J. Wahren, K. Ekberg and H. Jornvall

Pleiotrophin as a Possible New Target for Angiogenesis-Related Diseases and Cancer

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 2,Issue: 2
Page: 175-186
Authors: Constantinos Mikelis, Marina Koutsioumpa and Evangelia Papadimitriou

N-Phenylamine Derivatives as Aggregation Inhibitors in Cell Models of Tauopathy

Journal: Current Alzheimer Research
Volume: 4,Issue: 4
Page: 397-402
Authors: M. Pickhardt, J. Biernat, I. Khlistunova, Y.-P. Wang, Z. Gazova, E.-M. Mandelkow and E. Mandelkow

Neurorescue Activity, APP Regulation and Amyloid-β Peptide Reduction by Novel Multi-Functional Brain Permeable Iron- Chelating- Antioxidants,M-30 and Green Tea Polyphenol, EGCG

Journal: Current Alzheimer Research
Volume: 4,Issue: 4
Page: 403-411
Authors: Yael Avramovich-Tirosh, Lydia Reznichenko, Tamar Amit, Hailin Zheng, Mati Fridkin, Orly Weinreb, Silvia Mandel and Moussa B.H. Youdim

Alpha-Secretase As a Therapeutic Target

Journal: Current Alzheimer Research
Volume: 4,Issue: 4
Page: 412-417
Authors: Falk Fahrenholz

Cytoprotection by Melatonin, Precursors and Metabolites in an In Vitro Model of Neurotoxicity Induced by Okadaic Acid

Journal: Letters in Drug Design & Discovery
Volume: 2,Issue: 4
Page: 316-321
Authors: I. Tunez, R. Drucker-Colin, M. C. Munoz and P. Montilla

Topotecan and Irinotecan in the Treatment of Pediatric Solid Tumors

Journal: Current Pediatric Reviews
Volume: 1,Issue: 1
Page: 55-61
Authors: Yoshiaki Tsuchida and Toshiji Shitara

Preclinical Evaluation of no-Carrier-Added [131I]Meta-Iodobenzyl Guanidine, for the Treatment of Tumours Transfected with the Noradrenaline Transporter Gene

Journal: Letters in Drug Design & Discovery
Volume: 1,Issue: 1
Page: 50-57
Authors: M. Boyd, S. Ross, J. Owens, D. Hunter, J. Babich, M. R. Zalutsky, T. G. Hamilton, S. Bell and R. J. Mairs

Nogo Receptor Interacts with Brain APP and Aβ to Reduce Pathologic Changes in Alzheimers Transgenic Mice

Journal: Current Alzheimer Research
Volume: 4,Issue: 5
Page: 568-570
Authors: James H. Park and Stephen M. Strittmatter

Synthesis of Bicyclic Aryl Thiazolines with Selective Anti-Proliferative Effects on Human Cancer Cell Lines

Journal: Letters in Organic Chemistry
Volume: 5,Issue: 2
Page: 103-109
Authors: Laurent Brard, Rakesh K. Singh, Thilo S. Lange, Kyu K. Kim, Ajay P. Singh, Russell Hopson and Nicholi Vorsa

LGI1 Affects Survival of Neuroblastoma Cells by Inhibiting Signalling through Phosphoinositide 3-Kinase

Journal: Current Signal Transduction Therapy
Volume: 3,Issue: 2
Page: 129-132
Authors: Nadia Gabellini and Valentina Masola

CDK9 a Potential Target for Drug Development

Journal: Medicinal Chemistry
Volume: 4,Issue: 3
Page: 210-218
Authors: Fernanda Canduri, Patricia Cardoso Peres, Rafael Andrade Caceres and Walter Filgueira de Azevedo Jr.

The Cholesterol Transport Inhibitor U18666a Regulates Amyloid Precursor Protein Metabolism and Trafficking in N2aAPP “Swedish” Cells

Journal: Current Alzheimer Research
Volume: 5,Issue: 5
Page: 448-456
Authors: Warren Davis Jr.

Increased Aβ1-42 Production Sensitizes Neuroblastoma Cells for ER Stress Toxicity

Journal: Current Alzheimer Research
Volume: 5,Issue: 5
Page: 469-474
Authors: Sidhartha M. Chafekar, Rob Zwart, Robert Veerhuis, H. Vanderstichele, Frank Baas and Wiep Scheper

Research Advances in Neuroblastoma Immunotherapy

Journal: Current Pediatric Reviews
Volume: 5,Issue: 2
Page: 112-117
Authors: Latania Y. Booker, Titilope A. Ishola, Kanika A. Bowen and Dai H. Chung

Confocal Microscopy Evidence of Prion Protein Fragment hPrP[173-195] Internalization in Rat B104 Neuroblastoma Cell Line

Journal: Protein & Peptide Letters
Volume: 16,Issue: 11
Page: 1281-1290
Authors: Emanuela Urso, Raffaele Acierno, Maria Giulia Lionetto, Antonia Rizzello, Andrea Papa, Trifone Schettino and Michele Maffia

Modulation of Amyloid β Peptide1-42 Cytotoxicity and Aggregation in Vitro by Glucose and Chondroitin Sulfate

Journal: Current Alzheimer Research
Volume: 7,Issue: 5
Page: 428-438
Authors: X. Fernandez-Busquets, J. Ponce, R. Bravo, M. Arimon, T. Martianez, A. Gella, J. Cladera and N. Durany

Tyrosol and Hydroxytyrosol Two Main Components of Olive Oil, Protect N2a Cells Against Amyloid-β-Induced Toxicity. Involvement of the NF-κB Signaling

Journal: Current Alzheimer Research
Volume: 8,Issue: 5
Page: 543-551
Authors: C. St-Laurent-Thibault, M. Arseneault, F. Longpre and C. Ramassamy

Pharmacological Inhibition of Hsp90 as a Novel Antitumor Strategy to Target Cytoarchitecture Through Extracellular Matrix Signaling

Journal: Medicinal Chemistry
Volume: 7,Issue: 5
Page: 454-465
Authors: Vishal Chaturvedi, Jonnala Ujwal Kumar, Khande Rao Paithankar, Perumal Vanathi and Amere Subbarao Sreedhar

Inhibition of Apoptosis in Pediatric Cancer by Survivin

Journal: Current Pediatric Reviews
Volume: 7,Issue: 4
Page: 277-284
Authors: Ayman Samkari and Rachel A. Altura

Calcium Level Controlling Activities of Novel Derivatives of Amlodipine,Riodipine and Cerebrocrast

Journal: Letters in Drug Design & Discovery
Volume: 9,Issue: 3
Page: 322-328
Authors: R. Vilskersts, B. Vigante, Z. Neidere, A. Krauze, I. Domracheva, L. Bekere, I. Shestakova, G. Duburs and M. Dambrova

Novel Drugs for Neuroblastoma

Journal: Drug Design Reviews - Online (Discontinued)
Volume: 2,Issue: 7
Page: 527-535
Authors: Elzbieta Izbicka and Tadeusz Izbicki

An Update on the Other Telomerase Inhibitors: Non-G-Quadruplex Interactive Agent, Non-Antisense, Non-Reverse Transcriptase Telomerase Inhibitors

Journal: Medicinal Chemistry Reviews - Online (Discontinued)
Volume: 2,Issue: 4
Page: 325-343
Authors: L. A. Beltz and K. P. Manfredi

Prion Diseases: Time for a Therapy ?

Journal: Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume: 3,Issue: 2
Page: 185-197
Authors: Gianluigi Forloni, Maria Rosaria Vari, Laura Colombo, Orso Bugiani, Fabrizio Tagliavini and Mario Salmona

The ‘Other’ Telomerase Inhibitors: Non-G-Quadruplex Interactive Agent, Non-Antisense, Non-Reverse Transcriptase Telomerase Inhibitors

Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 2,Issue: 5
Page: 589-603
Authors: L. A. Beltz

Advances in α(v)β(3) Integrin-Targeting Cancer Therapy and Imaging with Radiolabeled RGD Peptides

Journal: Current Radiopharmaceuticals
Volume: 2,Issue: 3
Page: 214-219
Authors: Petar M. Mitrasinovic

Oncoproteomics of Neuroblastoma: A Blueprint for Future Progress

Journal: Current Proteomics
Volume: 7,Issue: 1
Page: 1-14
Authors: Hari R. Kumar, Xiaoling Zhong, Robert J. Hickey, Linda H. Malkas and John A. Sandoval

Overcoming Cell Death and Tau Phosphorylation Mediated by PI3KInhibition: A Cell Assay to Measure Neuroprotection

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 10,Issue: 2
Page: 208-214
Authors: D. Simon, M. Medina, J. Avila and F. Wandosell

Mechanisms Involved in BACE Upregulation Associated to Stress

Journal: Current Alzheimer Research
Volume: 9,Issue: 7
Page: 822-829
Authors: Eva Martisova, Maite Solas, Gorka Gerenu, Fermin I. Milagro, Javier Campion and Maria J. Ramirez

Paraneoplastic Neurological Syndromes - Diagnosis and Management

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 29
Page: 4518-4525
Authors: Franz Blaes

Genome-Wide Expression Analysis of Valproate Action: A Systems Level Synthesis

Journal: Current Psychopharmacology
Volume: 1,Issue: 4
Page: 315-326
Authors: Abhay Sharma

Polysialyltransferase: A New Target in Metastatic Cancer

Journal: Current Cancer Drug Targets
Volume: 12,Issue: 8
Page: 925-939
Authors: R .A. Falconer, R .J. Errington, S .D. Shnyder, P .J. Smith and L .H. Patterson

Cell Survival Signaling in Neuroblastoma

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 4
Page: 563-575
Authors: Michael L. Megison, Lauren A. Gillory and Elizabeth A. Beierle

TRAIL-Based Therapeutic Approaches for the Treatment of Pediatric Malignancies

Journal: Current Medicinal Chemistry
Volume: 20,Issue: 17
Page: 2254-2271
Authors: C. Gasparini, L. Vecchi Brumatti, L. Monasta and G. Zauli

Functionalized Mesoporous Silica Nanoparticles: A Possible Strategy to Target Cancer Cells Reducing Peripheral Nervous System Uptake

Journal: Current Medicinal Chemistry
Volume: 20,Issue: 20
Page: 2589-2600
Authors: C. Ceresa, G. Nicolini, R. Rigolio, M. Bossi, L. Pasqua and G. Cavaletti

Targeting Vascular Endothelial Growth Factor in Neuroblastoma

Journal: Current Angiogenesis (Discontinued)
Volume: 2,Issue: 1
Page: 30-39
Authors: Danielle Hsu, Jason M. Shohet and Eugene S. Kim

Blockade of Ser16-Hsp20 Phosphorylation Attenuates Neuroprotection Dependent Upon Bcl-2 and Bax

Journal: Current Neurovascular Research
Volume: 10,Issue: 3
Page: 208-215
Authors: Liuwang Zeng, Jieqiong Tan, Wei Lu and Zhiping Hu

Interplay Between Cholesterol and Homocysteine in the Exacerbation of Amyloid-β Toxicity in Human Neuroblastoma Cells

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 12,Issue: 6
Page: 842-848
Authors: Aydé Mendoza-Oliva, Patricia Ferrera and Clorinda Arias

Beta Caryophyllene and Caryophyllene Oxide, Isolated from Aegle Marmelos, as the Potent Anti-inflammatory Agents against Lymphoma and Neuroblastoma Cells

Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 13,Issue: 1
Page: 45-55
Authors: Soumyadeep Sain, Pravin K. Naoghare, S. Saravana Devi, Atul Daiwile, K. Krishnamurthi, P. Arrigo and T. Chakrabarti

The Interaction Between FAK, MYCN, p53 and Mdm2 in Neuroblastoma

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14,Issue: 1
Page: 46-51
Authors: Alicia M. Waters and Elizabeth A. Beierle

Statins and Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14,Issue: 5
Page: 706-712
Authors: Natalia G. Vallianou, Alexandra Kostantinou, Marios Kougias and Christos Kazazis

SPARC in Tumor Pathophysiology and as a Potential Therapeutic Target

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 39
Page: 6182-6190
Authors: Jianguo Feng and Liling Tang

Novel Histone Deacetylase Inhibitors for the Treatment of Pediatric Brain Tumors

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 14,Issue: 2
Page: 90-95
Authors: Pamela V. de Andrade, Augusto F. Andrade, Rosane G. de Paula Queiroz, Felipe A. Trevisan, Luiz G. Tone and Elvis T. Valera

A Review on the Synthesis and Anti-cancer Activity of 2-substituted Quinolines

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 5
Page: 631-646
Authors: Kaalin Gopaul, Suhas A. Shintre and Neil A. Koorbanally

HspB8 is Neuroprotective during Oxygen Glucose Deprivation and Reperfusion

Journal: Current Neurovascular Research
Volume: 12,Issue: 1
Page: 63-72
Authors: Binbin Yang, He Zhang, Xiaoye Mo, Han Xiao and Zhiping Hu

HIV-1 Subtypes B and C Tat Differentially Impact Synaptic Plasticity Expression and Implicates HIV-Associated Neurocognitive Disorders§

Journal: Current HIV Research
Volume: 12,Issue: 6
Page: 397-405
Authors: Thangavel Samikkannu, Venkata S.R. Atluri, Adriana Y. Arias, Kesava V.K. Rao, Carmen T. Mulet, Rahul D. Jayant and Madhavan P.N. Nair

Current Management of Neonatal Neuroblastoma

Journal: Current Pediatric Reviews
Volume: 11,Issue: 3
Page: 179-187
Authors: Rodrigo B. Interiano and Andrew M. Davidoff

Diagnostic Imaging of Fetal and Neonatal Abdominal and Soft Tissue Tumors

Journal: Current Pediatric Reviews
Volume: 11,Issue: 3
Page: 143-150
Authors: Usha D. Nagaraj and Beth M. Kline-Fath

The Association of Palmitoylethanolamide with Luteolin Decreases Neuroinflammation and Stimulates Autophagy in Parkinson's Disease Model

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14,Issue: 10
Page: 1350-1365
Authors: Rosalba Siracusa, Irene Paterniti, Daniela Impellizzeri, Marika Cordaro, Rosalia Crupi, Michele Navarra, Salvatore Cuzzocrea and Emanuela Esposito

Ouabain-Induced Signaling and Cell Survival in SK-N-SH Neuroblastoma Cells Differentiated by Retinoic Acid

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 14,Issue: 10
Page: 1343-1349
Authors: Evgeny E. Akkuratov, Jian Wu, David Sowa, Zahoor A. Shah and Lijun Liu

MYC as Therapeutic Target for Embryonal Tumors: Potential and Challenges

Journal: Current Cancer Drug Targets
Volume: 16,Issue: 1
Page: 2-21
Authors: Tarek Shalaby and Michael A. Grotzer

Genetics of Bladder Malignant Tumors in Childhood

Journal: Current Genomics
Volume: 17,Issue: 1
Page: 14-32
Authors: Andrea Zangari, Johan Zaini and Caterina Gulia

Pyrazolopyrimidine Derivatives as Antineoplastic Agents: with a Special Focus on Thyroid Cancer

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 16,Issue: 2
Page: 86-93
Authors: Silvia Martina Ferrari, Concettina La Motta, Stefania Sartini, Enke Baldini, Gabriele Materazzi, Ugo Politti, Ilaria Ruffilli, Salvatore Ulisse, Paolo Miccoli, Alessandro Antonelli and Poupak Fallahi

Multi-modal Anti-cancer Activities Provided by a Non-replicating Sendai Virus Envelope

Journal: Current Cancer Therapy Reviews
Volume: 11,Issue: 3
Page: 188-198
Authors: Yasufumi Kaneda

S100b Induces Expression of Myoglobin in APβ Treated Neuronal Cells In Vitro: A Possible Neuroprotective Mechanism

Journal: Current Aging Science
Volume: 9,Issue: 4
Page: 279-283
Authors: Maria E. Clementi, Beatrice Sampaolese and Bruno Giardina

Targeting Ras Activity Prevented Amyloid Beta-Induced Aberrant Neuronal Cell Cycle Re-Entry and Death

Journal: Current Alzheimer Research
Volume: 13,Issue: 11
Page: 1267-1276
Authors: M. Murat Koseoglu, Bagdeser Akdogan Ozdilek, Umidahan Djakbarova and Ayse Gulusur

New Therapeutic Property of Dimebon as a Neuroprotective Agent

Journal: Current Medicinal Chemistry
Volume: 23,Issue:
Page: 1-12
Authors: Aleksey Ustyugov, Elena Shevtsova, George E. Barreto, Ghulam Md. Ashraf, Sergey O. Bachurin and Gjumrakch Aliev

Anticancer, Antioxidant and Cytotoxic Potential of Thymol in vitro Brain Tumor Cell Model

Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 17,Issue: 2
Page: 116-122
Authors: Elanur Aydın*, Hasan Turkez, Sener Tasdemir and Fazıl Hacımuftuoglu

FTIR Spectroscopy Analysis can Highlight Induced Damage in Neuronallike Cells and Bio-protective Effectiveness of Agmatine

Journal: Current Metabolomics
Volume: 6,Issue: 1
Page: 34-39
Authors: Nadia Ferlazzo, Emanuele Calabro, Monica Curro, Daniela Caccamo, Salvatore Magazu and Riccardo Ientile*

In Vitro Sensitivity Profiling of Neuroblastoma Cells Against A Comprehensive Small Molecule Kinase Inhibitor Library to Identify Agents for Future Therapeutic Studies

Journal: Current Cancer Drug Targets
Volume: 17,Issue: 6
Page: 569-584
Authors: Anjali Singh, Vanessa Meier-Stephenson, Aarthi Jayanthan and Aru Narendran*

Nano-Delivery in Pediatric Tumors: Looking Back, Moving Forward

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17,Issue: 10
Page: 1328-1343
Authors: Marta Colletti, Virginia Di Paolo, Angela Galardi, Giuseppe Maria Milano, Angela Mastronuzzi, Franco Locatelli and Angela Di Giannatale*

Inhibition of Angiogenesis as a Treatment Strategy for Neuroblastoma

Journal: Current Cancer Therapy Reviews
Volume: 13,Issue: 1
Page: 43-62
Authors: Ankita Maji, Sachin M and Dwaipayan Sen*

The Novel Synthesized Pyridazinone Derivates had the Antiproliferative and Apoptotic Effects in SHSY5Y and HEP3B Cancer Cell Line

Journal: Letters in Organic Chemistry
Volume: 15,Issue: 4
Page: 323-331
Authors: Osman Ciftci*, Zeynep Ozdemir, Ceren Acar, Mert Sozen, Nese Basak-Turkmen, Idris Ayhan and Harika Gozukara

A Peptide Based Pro-Drug Ameliorates Amyloid-β Induced Neuronal Apoptosis in In Vitro SH-SY5Y Cells

Journal: Current Alzheimer Research
Volume: 14,Issue: 12
Page: 1293-1304
Authors: Sourav Kumar, Ashim Paul, Sourav Kalita, Awanish Kumar, Saurabh Srivastav, Somoday Hazra, Anup Kumar Ghosh, Bhubaneswar Mandal and Amal Chandra Mondal*

Eremurus spectabilis, Rich Source of Isoorientin: Isolation, Quantification and Anti-Cancer Activity on SH-SY5Y Neuroblastoma Cells

Journal: Current Pharmaceutical Analysis
Volume: 13,Issue:
Page: 1-8
Authors: Esen Sezen Karaoğlan*, Gülşah Gündoğdu, Mücahit Seçme, Onur Senol, Fatma Demirkaya Miloğlu, Yavuz Dodurga and Ali Rıza Tüfekçi

A Comparative Study of Synthetic Approaches Towards Total Synthesis of Mandelalide A, An Anti-Lung Cancer Metabolite From Lissoclinum Ascidian

Journal: Current Organic Chemistry
Volume: 22,Issue: 2
Page: 101-127
Authors: Ghulam Shabir and Aamer Saeed*

MicroRNAs in Neuroblastoma: Biomarkers with Therapeutic Potential

Journal: Current Medicinal Chemistry
Volume: 25,Issue: 5
Page: 584-600
Authors: Angela Galardi, Marta Colletti, Pietro Businaro, Concetta Quintarelli, Franco Locatelli and Angela Di Giannatale*

Review: The Role of Radiolabeled DOTA-Conjugated Peptides for Imaging and Treatment of Childhood Neuroblastoma

Journal: Current Radiopharmaceuticals
Volume: 11,Issue: 1
Page: 14-21
Authors: Natasha Alexander, Reza Vali, Hojjat Ahmadzadehfar, Amer Shammas and Sylvain Baruchel*

Amyloid-β Inhibits PDGFβ Receptor Activation and Prevents PDGF-BBInduced Neuroprotection

Journal: Current Alzheimer Research
Volume: 15,Issue: 7
Page: 618-627
Authors: Hui Liu, Golam T. Saffi, Maryam S. Vasefi, Youngjik Choi, Jeff S. Kruk, Nawaz Ahmed, Nyasha Gondora, John Mielke, Zoya Leonenko and Michael A. Beazely*

Biological and Genetic Features of Neuroblastoma and Their Clinical Importance

Journal: Current Pediatric Reviews
Volume: 14,Issue:
Page: 1-18
Authors: Nevim Aygun*

Riluzole Inhibits Proliferation, Migration and Cell Cycle Progression and Induces Apoptosis in Tumor Cells of Various Origins

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18,Issue: 4
Page: 565-572
Authors: Marta Kinga Lemieszek*, Andrzej Stepulak, Katarzyna Sawa-Wejksza, Arkadiusz Czerwonka, Chrysanthy Ikonomidou and Wojciech Rzeski

Association of Metronidazole with Cancer: A Potential Risk Factor or Inconsistent Deductions?

Journal: Current Drug Metabolism
Volume: 19,Issue:
Page: 1-8
Authors: Muhammad Adil, Waheed Iqbal, Fazal Adnan, Shabnam Wazir, Imran Khan, Mohammad Umar Khayam, Mohammad Amjad Kamal, Shafiq Ahmad, Jawad Ahmad and Ishaq N. Khan*